Connect with us

PR Newswire

Evox Therapeutics expands its existing exosome patent portfolio

Avatar

Published

on

OXFORD, England, Nov. 24, 2020 /PRNewswire/ — Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, is pleased to announce that the Company has been granted another key patent by the European Patent Office (EPO). This new grant reinforces the Company’s leading position within field of exosome therapeutics and adds to the growing number of foundational patent families within the Evox IP portfolio.  

The recently granted European patent (EP3463465) provides coverage for exosomes and methods of producing exosomes comprising an endogenous polypeptide-based release system for enabling luminal loading of soluble proteins inside an exosome. Such a release mechanism is important for optimal functional exosome-mediated delivery of soluble therapeutic proteins and enzymes into recipient cells.

Dr Antonin de Fougerolles, Chief Executive Officer of Evox, commented:

“We are pleased to have been granted another important patent within our rapidly growing therapeutic exosome patent estate. This patent provides broad protection for our internal pipeline programs, where we are using this approach to functionally deliver soluble enzymes into cells in order to correct rare metabolic diseases. It is also broadly applicable to delivery of other types of drug payloads where luminal loading inside an exosome is important.” 

About Evox Therapeutics

Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading life sciences venture capital groups and supported by a comprehensive intellectual property portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families. Evox uses its proprietary DeliverEXTM technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies, and Evox is leading the development within this emerging therapeutic space.

For further information visit: www.evoxtherapeutics.com 

SOURCE Evox Therapeutics

Related Links

http://www.evoxtherapeutics.com

Source: https://www.prnewswire.com:443/news-releases/evox-therapeutics-expands-its-existing-exosome-patent-portfolio-301178927.html

PR Newswire

Quali lève 54 millions de dollars en nouveau financement pour aider le DevOps d’entreprise à rationaliser la complexité de l’infrastructure

Avatar

Published

on

Greenfield Partners et JVP co-dirigent un nouveau cycle après des ventes record de la plate-forme CloudShell à Global 2000 et à des innovateurs du monde entier

AUSTIN, Texas, 20 janvier, 2021 /PRNewswire/ — Quali, l’entreprise d’Infrastructure Automation at Scale™ a annoncé aujourd’hui un nouveau financement de 54 millions de dollars, co-dirigé par Greenfield Partners et JVP. L’entreprise utilisera ces fonds pour élargir sa base de clients, créer de nouveaux partenariats, renforcer sa position de leader sur le marché, accélérer l’innovation de CloudShell et développer l’équipe de Quali.

La plate-forme CloudShell de Quali simplifie l’infrastructure cloud, la rendant accessible et sécurisée pour le développement et le déploiement d’applications, accélérant ainsi la transformation numérique. Quali a pour mission de débloquer la valeur commerciale grevée par les opérations technologiques et de libérer le temps et le talent des équipes technologiques pour qu’elles soient libres de bâtir l’avenir — développer, tester et déployer en libre-service simple à tout moment, sur n’importe quel cloud, ou même sur site.

Malgré la COVID-19, Quali a connu une année record, avec une croissance significative, au service de clients tels que Cisco, Microsoft, Dell, Verizon, plusieurs banques et fournisseurs de services cloud. Les investisseurs de Quali voient l’immense potentiel apporté par l’automatisation de masse. Outre le soutien continu de Kreos Capital, ce tour de financement accueille également un fonds géré par Hamilton Lane comme nouvel investisseur.

Alors que les acteurs traditionnels de l’infrastructure en tant que code (IaC) se sont concentrés sur un groupe relativement restreint d’experts, la technologie de Quali simplifie l’expérience utilisateur et rend l’infrastructure cloud et sa complexité invisibles pour les équipes en charge des applications qui en ont besoin.

« Les équipes de développement sont dépassées par le temps et la complexité de la mise en place et de l’exploitation de l’infrastructure du cloud. Quali permet aux développeurs de développer, aux testeurs de tester, aux planificateurs de planifier et aux exploitants d’exploiter en offrant un accès sûr et productif à l’infrastructure hybride du cloud, a expliqué Lior Koriat, PDG de Quali. Depuis le dernier financement de Quali en 2018, l’entreprise a connu une croissance rapide de ses ventes, l’innovation de sa plate-forme et a augmenté sa propre main-d’œuvre à l’échelle mondiale. »

« Quali a confirmé sa position comme leader du marché dans la catégorie DevOps et automatisation des infrastructures, en proposant ses services à des clients de niveau 1 sur de nombreux segments, a déclaré Erel Margalit, fondateur et président de JVP. C’est l’une de nos entreprises les plus fascinantes, et nous sommes heureux d’unir nos forces à celles de Shay Grinfeld, associé directeur chez Greenfield Partners, et de Boaz Dinte, associé directeur chez Qumra Capital, qui ont contribué à la création d’entreprises de premier plan dans cette catégorie, comme Jfrog, BigPanda et d’autres. Aux côtés de Yoav Tzruya, président de Quali, et de la vaste expérience de JVP dans la création d’entreprises internationales telles que CyberArk et QlikTech, nous sommes convaincus qu’avec la formidable équipe de Lior et Quali en Israël et aux États-Unis, l’entreprise occupera une place prépondérante. »

Shay Grinfeld, nouveau membre du conseil d’administration de Quali et associé directeur chez Greenfield Partners, a commenté : « Notre stratégie d’investissement consiste à s’appuyer sur la capacité unique de Quali à rationaliser la complexité du cloud et de l’infrastructure pour les équipes chargées des applications et de la technologie qui adoptent de plus en plus la méthodologie DevOps et les procédures CI/CD. Nous sommes impressionnés par leur récente croissance et sommes enthousiastes à l’idée de pouvoir bâtir une entreprise exceptionnelle. »

« Grâce à l’adoption croissante des bonnes pratiques DevOps et CI/CD, au-delà des premiers utilisateurs, les défis liés à la mise à l’échelle de ces pratiques sont de plus en plus répandus : éliminer les goulots d’étranglement opérationnels, de processus et de connaissances, réduire les coûts, assurer la gouvernance et unifier l’infrastructure. C’est à ce niveau que Quali tire son épingle du jeu, a déclaré Yoav Tzruya, associé général chez JVP et président de Quali. Alors que Atlassian et JFrog répondent aux besoins en matière de gestion des processus et de rationalisation du développement à la production, Quali se concentre sur l’abstraction et l’automatisation de l’infrastructure, permettant au CRO de se focaliser sur les ventes et non sur la complexité des démonstrations et des POC. Cela permet également aux développeurs de se consacrer au développement et de ne pas dépenser des ressources pour le provisionnement de l’informatique et du cloud, et aux opérations d’offrir la meilleure expérience client au lieu de s’occuper des coûts et de la gouvernance. »

« Ce qui m’attire chez Quali, c’est sa capacité à apporter la technologie d’automatisation essentielle directement aux masses (développeurs) sans nécessiter une expertise approfondie, a expliqué Boaz Dinte, membre du conseil d’administration de Qualiand JFrog. C’est la même chose qui m’a impressionné en tant que l’un des premiers investisseurs chez JFrog et je ne pourrais pas être plus enthousiaste quant à l’avenir de Quali. »

« Le cadre d’automatisation de Quali renforce encore notre capacité à construire l’avenir de demain aujourd’hui, permettant à Verizon de fournir de nouvelles technologies étonnantes à nos clients à la vitesse de DevOps », s’est réjoui John Musa, directeur chez Verizon Wireless.

Nouveaux clients : les entreprises de premier plan dans les secteurs de l’électronique grand public, des télécommunications, des services bancaires, de la technologie, des médias et plus encore font confiance à Quali pour accroître la productivité, accélérer la mise sur le marché et réduire les risques commerciaux.

Innovations : en plus de la configuration de l’infrastructure en un seul clic, la plate-forme CloudShell de Quali est la seule du secteur qui propose la désactivation automatique « sans clic » des environnements cloud ainsi que des capacités uniques de balisages automatiques, deux fonctionnalités essentielles à la visibilité et au contrôle des coûts du cloud.

Croissance des effectifs : avec des objectifs de recrutement ambitieux dans tous les domaines fonctionnels, Quali va presque doubler ses effectifs, en créant de nombreux postes dans ses nouveaux bureaux à Austin et Tel-Aviv, à travers les États-Unis, en Europe et en Asie.

Pour de plus amples informations sur les postes vacants, consultez https://www.quali.com/about-us/careers/.

À propos de Quali

Basée à Austin, au Texas, Quali a créé la plate-forme leader Infrastructure Automation at Scale. Des entreprises du Global 2000 et des innovateurs du monde entier font confiance à la plate-forme CloudShell primée de Quali pour créer des solutions d’automatisation en libre-service et à la demande qui augmentent la productivité de l’ingénierie, réduisent les coûts du cloud et optimisent l’utilisation de l’infrastructure. Pour de plus amples renseignements, veuillez consulter le site https://www.quali.com/ et suivez Quali sur Twitter et LinkedIn.

À propos de Greenfield Partners

Greenfield est une société d’investissement basée en Israël qui se concentre sur les entreprises technologiques en phase de croissance précoce. Présente à la fois à Tel-Aviv et à New York, l’équipe de Greenfield allie investissement et expérience opérationnelle, de profondes racines israéliennes locales et un vaste réseau mondial destiné à soutenir les entrepreneurs dans leur quête de création d’entreprises technologiques florissantes. Les racines de Greenfield remontent à 2016, lorsqu’elle a été créée par TPG Growth comme plate-forme d’investissement pour les investissements technologiques en début de croissance en Israël. Fonds indépendant depuis 2020, sa culture demeure ancrée dans ce patrimoine, apportant la rigueur et la profondeur du capital-investissement aux investissements de croissance précoce. L’équipe de Greenfield continue d’agir à titre de conseillers principaux de TPG Growth et, dans ce contexte, recherche des occasions de collaboration sur certains investissements à grande échelle et en phase de croissance en Israël. Son portefeuille comprend des sociétés comme Avanan, BigPanda, Guardicore et Vast Data. De plus amples informations sur Greenfield Partners sont disponibles à l’adresse suivante www.greenfieldlp.com.

À propos de JVP

Jerusalem Venture Partners (JVP), fondé et dirigé par Erel Margalit, est un fonds de capital-risque de renommée internationale. Jusqu’à maintenant, JVP a levé 1,4 milliard de dollars auprès de neuf fonds, et a été classé à de nombreuses reprises par Preqin et d’autres sociétés comme l’une des dix entreprises de capital-risque les plus performantes au monde. JVP a créé plus de 150 entreprises, tirant parti d’un vaste réseau de partenaires et d’une expertise du marché permettant à des entreprises de devenir des leaders du marché mondial. JVP a récemment été choisi par la ville de New York et EDC pour diriger le centre de cybersécurité à New York. Parmi les entreprises pionnières du secteur israélien du capital-risque, JVP a joué un rôle déterminant dans la création de certaines des plus grandes entreprises hors d’Israël, en facilitant 12 introductions en bourse sur le NASDAQ, notamment CyberArk Software, QLIK Technologies et Cogent Communications, entre autres. https://www.jvpvc.com/

Related Links

https://www.quali.com/

SOURCE Quali

Source: https://www.prnewswire.com:443/news-releases/quali-leve-54-millions-de-dollars-en-nouveau-financement-pour-aider-le-devops-d-entreprise-a-rationaliser-la-complexite-de-l-infrastructure-889384954.html

Continue Reading

PR Newswire

Sixth Street to Acquire Talcott Resolution

Avatar

Published

on

Talcott Resolution is a leading strategic partner for the insurance industry, offering a broad range of execution-focused capabilities, state-of-the-art technology and analytics, and in-force and new business solutions that provide capital flexibility and risk management efficiencies. It manages over $90 billion in liabilities and surplus for approximately 900,000 customers across the span of the Talcott businesses, including nearly 600,000 annuity contract holders.

The investment by Sixth Street affirms the successful implementation of Talcott Resolution’s strategy since becoming independent from The Hartford in 2018, as well as its growth potential as a consolidation platform for the U.S. life and annuity market. The company will continue to be led by Chief Executive Officer and President Pete Sannizzaro and will remain headquartered in Windsor, Connecticut.

“We want to thank the consortium for their tremendous support over the past few years as we established Talcott Resolution as an independent growth platform for risk transfer solutions,” said Mr. Sannizzaro. “We are looking forward to our partnership with Sixth Street and the next chapter in Talcott’s evolution. Sixth Street’s commitment to expand its presence in the insurance industry along with its stable, long-term capital base will be significant catalysts for our company’s growth.”

“Over the last three years, it has been a pleasure to work together with Pete and the entire Talcott Resolution team, as well as The Hartford and the consortium’s exceptional investment partners, to strategically grow and reposition Talcott Resolution as a standalone company built for long-term, sustainable success,” said Richard Carbone, Chairman and Independent Director of Talcott Resolution. “We are proud of all that the company has accomplished since the acquisition, and this sale represents a highly successful outcome for the company and the entire investor group.”

“The Talcott Resolution team has a proven ability to initiate, execute, and deliver results and we look forward to continuing what the consortium started through their strategic investment in the company’s growth,” said Alan Waxman, Co-Founder and CEO of Sixth Street. “This is a significant step in our commitment to the insurance sector, and we are excited to be partnering with Pete and his experienced team.”

“We are pleased with the opportunity to be investing in and helping build a leading creative solutions provider to the insurance industry,” said A. Michael Muscolino, Co-Founder and Partner at Sixth Street. “With great support and guidance from their institutional investors, Pete and team have created a business with the reputation, capabilities, and expertise to take advantage of opportunities afforded by the current market environment.”

Sixth Street manages over $50 billion in assets and pursues investments in the insurance sector through its Sixth Street TAO platform, which consists of $25 billion in flexible, long-dated capital. Sixth Street’s team of dedicated insurance-focused investment professionals and experts focuses on strategic partnerships, corporate acquisitions, reinsurance, and other balance sheet bolstering transactions.

The transaction is expected to close in the second quarter of 2021, subject to regulatory approvals and other customary closing conditions.

J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. acted as financial advisors and Willkie Farr & Gallagher LLP acted as legal advisor to Sixth Street. Sidley Austin LLP acted as legal advisor to the consortium.

About Talcott Resolution

Talcott Resolution Life Insurance Company oversees over $90 billion in liabilities and surplus for approximately 900,000 customers. The company offers creative in-force and new business solutions that provide insurers with capital flexibility and risk management efficiencies. Named a “Top Workplace” by the Hartford Courant for 2019 and 2020, Talcott Resolution is headquartered in Windsor, Conn. For more information visit www.talcottresolution.com.

About Sixth Street

Sixth Street is a global investment firm with over $50 billion in assets under management and committed capital. We operate nine diversified, collaborative investment platforms: TAO, Growth, Specialty Lending, Fundamental Strategies, Infrastructure, Opportunities, Insurance, Agriculture, and Credit Market Strategies. Our long-term oriented, highly flexible capital base and “One Team” cultural philosophy allow us to invest thematically across sectors, geographies, and asset classes. Founded in 2009, Sixth Street has more than 320 team members including over 145 investment professionals in nine locations around the world. For more information about Sixth Street, visit www.sixthstreet.com or follow us on LinkedIn.

About Cornell Capital

Cornell Capital LLC is a U.S.-based private investment firm with over $4.0 billion of AUM and offices in New York and Hong Kong. Partnering with strong, entrepreneurial management teams, the firm takes a value-oriented approach to investing across the consumer, financial and industrial sectors. Founder and Senior Partner Henry Cornell, who served as the Vice Chairman of Goldman Sachs’ Merchant Banking Division prior to founding Cornell Capital in 2013, leads a highly-seasoned senior leadership team with decades of shared investing experience. For more information, visit www.cornellcapllc.com.

About Atlas Merchant Capital LLC

Atlas Merchant Capital LLC invests in compelling market opportunities in the financial services sector. Based in New York and London, Atlas Merchant Capital was founded by Bob Diamond and David Schamis, who together with their partners form a complementary partnership with extensive operating and investing expertise across the financial services landscape. Further information is available at www.atlasmerchantcapital.com.

About TRB Advisors LP

TRB Advisors LP is a private investment firm established in 2010 to exclusively manage the assets of Timothy Barakett and his family. TRB engages in a broad range of investment activities and seeks superior risk-adjusted returns through a long-term, patient, and flexible investment mandate. The firm’s investment professionals are led by Heath L. Watkin, President and Chief Investment Officer, and operate from TRB’s offices in New York City.

About Global Atlantic Financial Group

Global Atlantic Financial Group, through its subsidiaries, offers a broad range of retirement, life and reinsurance products designed to help our clients address financial challenges with confidence. Global Atlantic offers custom solutions and responsive service for the capital, risk and legacy-business management of life and annuity insurance companies around the world.

Global Atlantic was founded at Goldman Sachs in 2004 and separated as an independent company in 2013. Global Atlantic’s success is driven by a unique heritage that combines deep product and distribution knowledge with leading investment and risk management, alongside a strong financial foundation of more than $90 billion in assets, as of June 30, 2020.

About Pine Brook

Pine Brook has approximately $4.4 billion of assets under management across two investment strategies: Financial Services and Energy. Through dedicated, sector-focused teams, Pine Brook makes “business building” and other investments that drive growth. Pine Brook’s team of investment professionals has experience financing the growth of businesses with equity, working alongside talented entrepreneurs and experienced management teams to build businesses of scale. For more information about Pine Brook, please visit the company’s web site at www.pinebrookpartners.com.

About J. Safra Group

The J. Safra Group (the “Group”), with total assets under management of over USD 270 billion and aggregate stockholders equity of USD 19.6 billion, consists of privately owned banks under the Safra name and investment holdings in asset based business sectors such as real estate and agribusiness. The Group’s banking interests in over 160 locations globally, are: J. Safra Sarasin, headquartered in Basel, Switzerland; Banco Safra, headquartered in Sao Paulo, Brazil; and Safra National Bank of New York, headquartered in New York City, all independent from one another from a consolidated supervision standpoint. The Group’s real estate holdings consist of more than 200 premier commercial, residential, retail and farmland properties worldwide, such as New York City’s 660 Madison Avenue office complex and London’s iconic Gherkin Building. Its investments in other sectors include, among others, agribusiness holdings in Brazil and Chiquita Brands International Inc. With deep relationships in markets worldwide, the Group is able to greatly enhance the value of businesses which are part of it. There are more than 35,000 employees associated with the J. Safra Group.

About The Hartford

The Hartford is a leader in property and casualty insurance, group benefits and mutual funds. With more than 200 years of expertise, The Hartford is widely recognized for its service excellence, sustainability practices, trust and integrity. More information on the company and its financial performance is available at https://www.thehartford.com. Follow us on Twitter at @TheHartford_PR.

The Hartford Financial Services Group, Inc., (NYSE: HIG) operates through its subsidiaries under the brand name, The Hartford, and is headquartered in Hartford, Connecticut. For additional details, please read The Hartford’s legal notice.

SOURCE Talcott Resolution

Related Links

https://www.talcottresolution.com

Source: https://www.prnewswire.com:443/news-releases/sixth-street-to-acquire-talcott-resolution-301211628.html

Continue Reading

PR Newswire

Global Laboratory Information Management Systems Market (2020 to 2027) – Featuring Abbott Informatics, Accelerated Technology Laboratories & Autoscribe Informatics Among Others

Avatar

Published

on

DUBLIN, Jan. 20, 2021 /PRNewswire/ — The “Global Laboratory Information Management Systems (LIMS) Market Analysis 2020” report has been added to ResearchAndMarkets.com’s offering.

The Global Laboratory Information Management Systems (LIMS) market is expected to reach $2.21 billion by 2026 growing at a CAGR of 14.1% during 2019 to 2026. Laboratory Information Management Systems (LIMS) is software that is used for managing various tasks in the laboratory including workflow management, integrate instruments, records management, logistics management, enterprise resource planning, decision making, privacy and security controls. Laboratories generate ample amount of data which can be managed through LIMS.

Factors such as growing adoption of cloud-based LIMS, technological advancements in LIMS offerings and growing R&D expenditure in pharmaceutical and biotechnology companies are driving the market growth. However, high maintenance and service costs and lack of integration standards for LIMS are restraining the market growth. Moreover, use of LIMS in the cannabis industry may provide ample opportunities for the market growth

Based on end user, the life sciences/ pharmaceutical laboratories segment is going to have a lucrative growth. The large share of this segment can be attributed to the increasing number of biobanks/biorepositories, growing R&D investments/activities in pharmaceutical and biotechnology companies, and rise in outsourcing by pharmaceutical companies. Apart from this, LIMS provides higher productivity and cost efficiency, which is to bolster its deployment in the life science sector.

The key vendors mentioned are Abbott Informatics, Accelerated Technology Laboratories, Autoscribe Informatics, Genologics, LabLynx Inc, LabVantage Solutions Inc, LabWare, Labworks, Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

  • How this market evolved since the year 2018
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

Key Topics Covered:

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Laboratory Information Management Systems (LIMS) Market, by LIMS Type
5.1 Introduction
5.2 Industry-Specific LIMS
5.3 Broad-Based LIMS

6 Global Laboratory Information Management Systems (LIMS) Market, by Type
6.1 Introduction
6.2 Integrated
6.3 Standalone

7 Global Laboratory Information Management Systems (LIMS) Market, by Purpose Type
7.1 Introduction
7.2 Multipurpose
7.3 Purpose Built

8 Global Laboratory Information Management Systems (LIMS) Market, by Component
8.1 Introduction
8.2 Hardware
8.3 Services
8.4 Software

9 Global Laboratory Information Management Systems (LIMS) Market, by Deployment Model
9.1 Introduction
9.2 Cloud-Based LIMS
9.3 On-Premise LIMS
9.4 Remotely (On-premise & Cloud)
9.5 Web Hosted LIMS

10 Global Laboratory Information Management Systems (LIMS) Market, by Application
10.1 Introduction
10.2 Decision Making
10.3 Enterprise Resource Planning
10.4 Logistics Management
10.5 Records Management
10.6 Sample Management
10.7 Workflow Automation

11 Global Laboratory Information Management Systems (LIMS) Market, by End User
11.1 Introduction
11.2 Chemical/ Energy
11.3 Consumer Products
11.4 Diagnostics/Medical Device
11.5 Environmental Testing Laboratories
11.6 Food & Beverage and Agriculture
11.7 Hospitals & Clinics
11.8 Life Sciences/ Pharmaceutical Laboratories
11.9 Petrochemical Refineries and Oil & Gas
11.10 Research Centers
11.11 Agriculture Industry
11.12 Toxicology Laboratories
11.13 Next-Generation Sequencing Laboratories
11.14 Academic Research Institutes
11.15 Bio-Banks & Bio-Repositories
11.16 Pathology

12 Global Laboratory Information Management Systems (LIMS) Market, by Product Type
12.1 Introduction
12.2 MAC
12.3 Android
12.4 iOS
12.5 Windows

13 Global Laboratory Information Management Systems (LIMS) Market, by Industry Type
13.1 Introduction
13.2 School
13.3 Manufacture

14 Global Laboratory Information Management Systems (LIMS) Market, by Sales Channel
14.1 Introduction
14.2 Direct Channel
14.3 Distribution Channel

15 Global Laboratory Information Management Systems (LIMS) Market, by Geography
15.1 Introduction
15.2 North America
15.3 Europe
15.4 Asia Pacific
15.5 South America
15.6 Middle East & Africa

16 Strategic Benchmarking

17 Vendors Landscape
17.1 Abbott Informatics
17.2 Accelerated Technology Laboratories
17.3 Autoscribe Informatics
17.4 Genologics
17.5 LabLynx Inc
17.6 LabVantage Solutions Inc
17.7 LabWare
17.8 Labworks
17.9 Siemens AG
17.10 Thermo Fisher Scientific Inc

For more information about this report visit https://www.researchandmarkets.com/r/189a1o

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Source: https://www.prnewswire.com:443/news-releases/global-laboratory-information-management-systems-market-2020-to-2027—featuring-abbott-informatics-accelerated-technology-laboratories–autoscribe-informatics-among-others-301211609.html

Continue Reading

PR Newswire

Ultra X Boost Keto Review – Best Keto Diet Pills 2021 Market Reports

Avatar

Published

on

NEW YORK, Jan. 20, 2021 /PRNewswire/ — Ultra X Boost Keto: Fat collection in the body is a very concerning issue for people. The majority of people have been actively working towards making sure that the body gets to be free of unwanted fat. The problems such as heart issues, kidney problems, diabetes, etc are all caused majorly due to the unwanted fat which gets stored in the body. There are lots of people dying daily due to the problems caused by excess fat in their body. Thus the concerns related to excess fat being stored in the body must be resolved too. People do not have the time to go to the gym and getting free of fat by burning it through exercises. This is because of the hectic lifestyle that people follow. Thus they have been trying to find out ways through which they can get a better shape in no time. The usage of Best Keto Diet Pills has become more trustable today for burning off fat in less time. But not all Best Keto Diet Pills are completely healthy for the body. The pills which contain unhealthy chemical compounds have long-term side effects that can be harmful to the body. Thus finding the Ultra X Boost Keto available in the market is very important.

Ultra X Boost Keto- REPORT IN THE OFFICIAL WEBSITE: http://www.theketosis.org/

Many companies are selling their products for helping out people in losing excess weight. But it is up to the customer for choosing the right product and thus get free of fat without any side effects. The criteria for choosing the Ultra X Boost Keto are majorly the working of the pills, their actions on the body, ingredients that are used in them, the process through which the pills burn off the fat stored in the body. These criteria need to be fulfilled for making sure that the users make use of the right pills for losing weight without side effects or allergies being caused. There are many companies that try to hide such details about their products and people must stay away from such companies. Companies who are completely honest about their product can be relied upon. MUST SEE: “Shocking New Ultra X Keto Boost Report – This May Change Your Mind”

The Ultra X Boost Keto in the market at present cannot be put in a list of few products. There are a lot of products in the market and the best ones among them are the ones who have the best effects in no time. Many products such as one-shot keto, Divatrim keto, nature’s method keto, My keto boost, fast fit keto, etc have been the best sellers of the market as the users rely upon them. This is observed among a lot of healthy Best Keto Diet Pills that they mostly make use of ketosis as the process for burning off fat. Thus looking for ketosis as the process of fat loss being used in Best Keto Diet Pills can be a wise choice too. But going for just the ketosis based pills is not the only option either. There are many other products too that make use of other processes for burning off fat. Thus the choice is purely based on the ingredients being used and the way pills work to burn off fat.

Checking for the customer reviews about the Best Keto Diet Pills is a very important part of choosing the right option too. There are many medical websites and health magazines in the market at present that suggest such Best Keto Diet Pills. Reading the options available there and the customer reviews can be very informative. These days health professionals such as fitness trainers also suggest Best Keto Diet Pills and listening to them can be helpful too. Thus choosing the Ultra X Boost Keto is not so hard if people look for the right choice in getting a better shape.

Choosing the Ultra X Boost Keto for the body is a task that people have to undertake to gain proper shape and therefore many scientists and researchers have already gotten onto making sure that they deliver the right choice to people. Many pharmaceutical companies have gotten in the race of giving the right pills that can help in ensuring proper shape for the body and thus the users have many choices available to them. For getting the perfect shape for the body, people must choose Best Keto Diet Pills according to the lifestyle that they have. For the people who have a corporate lifestyle with no free time to do exercises, they must choose pills that work just with the diet and require no exercise schedule.

Such dietary pills work efficiently to help people lose weight. For the people who can go to gyms and all, they can choose to have Best Keto Diet Pills that work efficiently with their exercise schedule. There are many choices for people in both pills. The most important point that people have to keep in their minds while choosing pills is the nutrient content of those pills. Ultra X Boost Keto has 60% proteins, 35% vitamins, 4.5% carbs, and rest as roughage in them. This makes sure that the body gets properly nourished and hence helps in muscle gain and recovery. The Best Keto Diet Pills are somewhat different in nutrient contents but the protein intake is the same in them too.

Ultra X Boost Keto Official Website: http://www.theketosis.org/

Ultra X Boost Keto
[email protected]
TOLL FREE (888) 498-1225

SOURCE Ultra X Boost Keto

Source: https://www.prnewswire.com:443/news-releases/ultra-x-boost-keto-review—best-keto-diet-pills-2021-market-reports-301211625.html

Continue Reading
Blockchain4 days ago

The Countdown is on: Bitcoin has 3 Days Before It Reaches Apex of Key Formation

Blockchain3 days ago

Litecoin, VeChain, Ethereum Classic Price Analysis: 17 January

Blockchain4 days ago

Is Ethereum Undervalued, or Polkadot Overvalued?

Blockchain4 days ago

Here’s why Bitcoin or altcoins aren’t the best bets

Blockchain4 days ago

Chainlink Futures OI follows asset’s price to hit ATH

PR Newswire5 days ago

The merger of FCA and Groupe PSA has been completed

Blockchain2 days ago

5 Best Bitcoin Alternatives in 2021

Blockchain3 days ago

Data Suggests Whales are Keen on Protecting One Key Bitcoin Support Level

SPACS5 days ago

Affinity Gaming’s SPAC Gaming & Hospitality Acquisition files for a $150 million IPO

Blockchain3 days ago

Bitcoin Worth $140 Billion Lost Says UK Council

Blockchain3 days ago

Bitcoin Cash Price Analysis: 17 January

NEWATLAS5 days ago

Small, slick French camper van is the bivy of van life

Blockchain3 days ago

eToro’s New Bitcoin Account Incentives Are So Good, They Had To Disable Buy Orders

Blockchain2 days ago

Mitsubishi and Tokyo Tech Tap Blockchain for P2P Energy Trading Network

Blockchain3 days ago

Cardano, Cosmos, BAT Price Analysis: 17 January

Blockchain4 days ago

Mt. Gox Creditors Could Get Bankruptcy-tied Bitcoin

Blockchain4 days ago

Grayscale’s Bitcoin Trust adds over 5k BTC in 24 hours

Blockchain2 days ago

New Highs Inbound: Ethereum is About to See an Explosive Rally Against BTC

Blockchain3 days ago

Why Bitcoin denominated payments won’t be mainstream anytime soon

Cyber Security1 day ago

Rob Joyce to Take Over as NSA Cybersecurity Director

Trending